Veterinary Hospital Market Size & Share 2026-2035

Veterinary Hospital Market Size

The global veterinary hospital market was valued at USD 67.8 billion in 2025. It is projected to reach USD 132.8 billion by 2035, expanding at a 7.1% CAGR from 2026 to 2035.

Demand is shifting from episodic treatment toward broader clinical management of companion animals, including preventive screening, chronic-condition monitoring, specialty referral, and advanced procedures. The addressable patient base remains substantial: the American Veterinary Medical Association reports 87.3 million dogs and 76.3 million cats in the United States, while 56.3 million U.S. households own dogs and 43.1 million own cats ^{[1]American Veterinary Medical Association, U.S. Pet Ownership Statistics, 2025, avma.org}. Pet ownership growth is not confined to mature markets. Mars Petcare's 2024 global study estimated that roughly one billion pets are kept worldwide and found that 47% of surveyed dog and cat owners were first-time owners.

Higher utilization is increasingly supported by insurance. U.S. pet insurance gross written premium exceeded USD 4.7 billion in 2024, rising 21.4% from the preceding year ^{[2]American Veterinary Medical Association, U.S. pet insurance industry surpasses $4.7B in 2024, April 2025, avma.org}. Insurance does not remove affordability constraints, but it can change the treatment decision at the point of care by making imaging, laboratory panels, specialist referral, and chronic-disease protocols more attainable for covered animals.

Provider economics are being reshaped at the same time. Corporate networks can spread the fixed cost of diagnostic platforms, emergency staffing, referral infrastructure, procurement, and digital administration across multiple sites. AAHA's review of Brakke Consulting and PitchBook data indicated that corporate consolidators accounted for approximately half of U.S. veterinary market revenue by 2021, while specialty and emergency practices had a substantially higher corporate ownership share than general practices. This ownership shift matters because advanced service adoption depends as much on staffing and capital deployment as on client demand.

Technology is extending the scope of services that can be delivered during a single visit. IDEXX introduced its inVue Dx slide-free cellular analyzer in January 2024, positioning cytology and hematology results within a ten-minute workflow. Zoetis expanded Vetscan Imagyst with AI urine sediment analysis in the same month, while Antech introduced AIS RapidRead for AI-assisted radiology interpretation during 2024. These systems can shorten the interval between presentation, diagnostic confirmation, and treatment planning, which is commercially material where a delayed result would otherwise require another appointment or external referral.

This creates an uneven competitive outcome. Capitalized networks can acquire equipment, standardize protocols, centralize purchasing, and direct complex cases through referral systems. Independent hospitals retain meaningful advantages in local relationships and continuity of care, but their ability to capture the fastest-growing diagnostic and specialty revenue pools depends on access to trained staff, financing, and external laboratory or referral partnerships. The 7.13% forecast therefore reflects demand expansion moderated by the practical constraints of labor availability and treatment affordability.

The market scope covers veterinary hospital services delivered for companion animals, farm animals, and exotic animals and wildlife. It includes general veterinary, diagnostic, surgical, and other services across private and public ownership settings. Geographic coverage comprises North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Key Drivers

Growing animal population and rising pet ownership

Veterinary demand expands when ownership growth is accompanied by more intensive care expectations. In the U.S., 95 million households owned at least one pet in 2025, and total pet-industry expenditure reached USD 158 billion. The same trend is visible in high-growth Asian markets. China's dog and cat population reached 124.1 million in 2024, including 71.5 million cats, according to the U.S. Department of Agriculture's Shanghai Agricultural Trade Office. India's pet population reached approximately 36.7 million in 2024 and was expected to approach 39 million in 2025.

Companion-animal humanization affects the composition of hospital revenue. Owners increasingly seek wellness testing, dental care, nutrition advice, imaging, oncology, and long-term treatment for geriatric conditions rather than using hospitals solely for vaccination or acute injury. The result is a larger lifetime value per patient, particularly for dogs and cats covered by insurance or managed through structured preventive-care plans.

Advancements in veterinary medicine

Diagnostic innovation is expanding the range of services performed at the point of care. IDEXX's inVue Dx system is designed to generate cellular-analysis results without conventional slide preparation, while Zoetis' Vetscan OptiCell uses cartridge-based, AI-enabled hematology analysis ^{[3]IDEXX Laboratories, IDEXX Announces Revolutionary Slide-Free Cellular Analyzer, IDEXX inVue Dx, January 2024, ir.idexx.com}. Antech's AIS RapidRead platform similarly brings automated radiographic interpretation into routine veterinary workflows. The commercial effect is not simply a higher test count; it is faster clinical decision-making, which can reduce owner attrition between the initial examination and a recommended diagnostic workup.

AI also has implications for workforce productivity. AVMA identified approximately 24 companies marketing AI-enabled veterinary tools in 2024, spanning clinical documentation, imaging, analytics, and operational support. These tools will not substitute for professional judgment or resolve specialist shortages, but they can reduce time spent on repetitive documentation and routine image-review tasks. Telehealth provides a related efficiency lever for triage, post-operative follow-up, behavioral consultations, and chronic-condition monitoring. Florida's 2024 action to permit a virtual veterinarian-client-patient relationship added momentum to a state-level regulatory shift toward more flexible virtual-care models.

Consolidation of animal hospitals

Consolidation has moved beyond ownership transfer into a service-delivery strategy. Larger hospital groups can establish specialist hubs, route referrals internally, negotiate equipment purchases, and maintain emergency coverage across regional networks. These capabilities are particularly relevant for capital-intensive modalities such as computed tomography, magnetic resonance imaging, advanced surgery, and in-clinic diagnostics.

Regulatory scrutiny is becoming a material counterweight. The Federal Trade Commission has examined veterinary hospital mergers through the lens of local geographic competition and access to specialty care. In the United Kingdom, the Competition and Markets Authority's veterinary-services review has similarly focused attention on local pricing transparency, ownership concentration, and consumer choice. These reviews may lengthen transaction timelines and require divestitures, but they do not eliminate the economic rationale for network formation where hospitals need scale to sustain specialist staffing and technology investment.

Growing prevalence of chronic and infectious diseases in animals

Chronic disease produces recurring clinical demand rather than a single treatment event. The Dog Aging Project reported that 33% of participating dogs had at least one ongoing medical condition. Separately, a study covering approximately 4.9 million dogs and 1.3 million cats treated at U.S. primary-care practices found that 50.1% of mature dogs were overweight or obese. Obesity is associated with orthopedic, endocrine, and cardiovascular complications that can require repeated monitoring, medication, dietary intervention, or surgery.

In production animals, infectious disease surveillance creates a separate source of demand. WOAH reported 943 new highly pathogenic avian influenza outbreaks in poultry across 42 countries during 2024 and 1,022 outbreaks among mammals. Such outbreaks increase demand for veterinary testing, biosecurity plans, herd-health management, and regulatory compliance. The revenue pattern differs from companion-animal care: it is more episodic and more dependent on livestock economics and public-health controls, but it supports the farm-animal service base in disease-exposed regions.

Key Restraints

High cost of advanced veterinary treatments

Price escalation can weaken utilization among uninsured households even when clinical need is high. U.S. veterinary-service prices rose 7.9% between February 2023 and February 2024, according to Bureau of Labor Statistics data reported by USA Today ^{[4]USA Today, How much is a vet visit? Behind the soaring cost of pet care, April 2024, usatoday.com}. Labor intensity, equipment depreciation, specialist compensation, and higher pharmaceutical and supply costs all contribute to the cost base. When treatment estimates rise beyond a household's budget, owners may defer diagnostic workups, decline referral, or select lower-cost interventions.

The affordability issue is most acute for complex or chronic treatment pathways. Nationwide reported that recurring care for conditions such as diabetes, kidney disease, inflammatory bowel disease, and dental disease can create substantial annual or episode-specific expenses. Insurance can temper out-of-pocket exposure for covered pets, but penetration remains limited relative to the total companion-animal population. This leaves hospitals managing a persistent tension between medically appropriate care and the owner's capacity to pay.

Shortage of skilled veterinary professionals

Workforce availability constrains opening hours, appointment capacity, specialty service expansion, and the speed at which acquired hospitals can be integrated into a network. A 2024 AAVMC-commissioned analysis projected that U.S. veterinary graduate supply would meet approximately 73% of projected demand through 2030 under its assumptions. The AVMA has noted, however, that an alternative Brakke Consulting analysis found that the profession may be able to meet companion-animal demand through 2035 when productivity and work-pattern assumptions are adjusted.

The disagreement is analytically important rather than merely academic. Long-term supply estimates vary with assumptions about hours worked, technician utilization, telehealth adoption, and AI-assisted productivity. Yet current operating conditions still indicate a practical constraint: hospitals must compete for veterinarians, veterinary technicians, emergency clinicians, and board-certified specialists. New colleges may increase capacity over time, but AVMA Journal analysis has emphasized that faculty availability and accreditation timelines can limit how quickly that supply reaches the market.

Technology is therefore strategically relevant because it may improve throughput rather than merely add a premium service. Documentation automation, in-clinic diagnostics, virtual follow-up, and better technician utilization can release veterinarian time for examinations and treatment decisions. However, the benefit will accrue unevenly. Networks with the resources to redesign workflows, recruit specialists, and absorb technology costs can improve capacity faster than smaller hospitals, while independent providers may face a widening gap in both service range and labor economics.

Veterinary Hospital Market Segment Analysis

By Animal Type

Companion animals account for 64.51% of 2025 market revenue and are forecast to grow at 7.1% CAGR. Dogs and cats underpin the segment because their owners are more likely to pursue preventive testing, chronic-disease treatment, elective procedures, and specialist referral. Dogs represent the largest expenditure pool in many markets, while feline care is gaining importance as cats become more prevalent in dense urban households, particularly in China ^{[5]U.S. Department of Agriculture Foreign Agricultural Service, Pet Food Market Update 2024, Shanghai ATO, China, 2024, apps.fas.usda.gov}. Horses and other companion animals require specialized services, but their narrower patient base limits their contribution relative to dogs and cats.

Farm animals account for 31.93% of market revenue and grow at 6.2% CAGR. Cattle, swine, poultry, and other production animals generate demand through herd-health programs, fertility management, vaccination, biosecurity, and outbreak response. Unlike companion-animal care, producer spending is closely tied to farm margins, export requirements, and disease-control regulation. HPAI and African swine fever risks maintain demand for surveillance and prevention, but commodity-price weakness can delay discretionary investment in herd-health services.

Exotic animals and wildlife represent 3.56% of 2025 revenue and grow at 5.6% CAGR. The segment includes zoo medicine, wildlife rehabilitation, avian and reptile medicine, and care for small exotic companion animals. Its growth is constrained by a limited pool of trained clinicians and the institutional character of wildlife medicine, which is often funded by universities, government bodies, zoos, or conservation organizations rather than scalable private-practice models.

By Services

General veterinary services hold the largest service share at 45.73% in 2025. Wellness examinations, vaccinations, parasite prevention, routine consultations, and dental prophylaxis remain the primary entry point into the hospital system. Their 6.8% CAGR reflects a mature base, although wellness plans and recurring preventive-care programs can stabilize client retention and create referral flows to higher-acuity services.

Diagnostic services represent 23.62% of 2025 revenue and have the highest service CAGR at 7.5%. Their growth rate reflects a shift in clinical workflow: blood analysis, cytology, radiography, ultrasound, and infectious-disease testing are increasingly performed or initiated during the initial encounter. AI-enabled systems reduce turnaround time and can make a more complete workup easier to present and authorize during a consultation ^{[6]Zoetis, Zoetis Further Expands Diagnostic Capabilities of Vetscan Imagyst Platform With Addition of AI Urine Sediment Analysis, January 2024, news.zoetis.com}.

Surgical services account for 21.13% of the market and grow at 7.1% CAGR. Revenue is concentrated in companion-animal dentistry, orthopedic procedures, soft-tissue surgery, oncology, and emergency intervention. The service category benefits from aging pets and from diagnostic improvements that identify surgical candidates earlier, but it remains sensitive to owner affordability because procedures often involve large single-event expenditures.

Other services account for 9.53% of revenue and grow at 6.2% CAGR. Rehabilitation, behavioral medicine, nutritional counseling, hospitalization, palliative care, and boarding-related services broaden the hospital's role across the patient lifecycle. These categories are particularly relevant to multi-site networks seeking to retain cases that might otherwise be referred externally or handled by non-clinical service providers.

By Ownership

Private hospitals hold 61.47% of 2025 revenue and grow at 7.5% CAGR. This category includes independent practitioner-owned clinics and corporate networks. Corporate ownership is accelerating adoption of advanced diagnostics and specialty services because groups can distribute capital expenses and centralize administrative functions. Independent hospitals remain central to the market, especially outside metropolitan referral hubs, but their investment decisions are more exposed to local cash flow and recruitment conditions.

Public providers account for 38.53% of market value and grow at 6.3% CAGR. University teaching hospitals, government veterinary facilities, military services, public rural networks, and zoo medicine serve functions that private hospitals do not always provide economically, including disease surveillance, veterinary education, rare-condition referral, and food-safety oversight. Their role is particularly significant in production-animal health and in regions where private veterinary infrastructure remains uneven.

General services will remain the volume foundation, but diagnostics are likely to capture a growing share of value because they influence what happens next in the care pathway. A blood panel, image interpretation, or cytology result can trigger medication, surgery, referral, monitoring, or a wellness plan. Hospitals that integrate those capabilities into primary-care workflows can capture a larger portion of lifetime patient spending; hospitals that cannot may increasingly function as lower-acuity access points within a more segmented referral market.

Veterinary Hospital Market Regional Analysis

North America

North America holds 39.71% of global revenue in 2025, valued at USD 26,934.15 million, and is forecast to grow at 7.9% CAGR. The region combines high companion-animal ownership, insurance growth, an established referral ecosystem, and deep corporate consolidation. Its growth is driven primarily by greater spend per patient rather than by a large increase in the number of pets.

The U.S. represents 91.12% of North American market value and grows at 7.0% CAGR. Large dog and cat populations, insurance expansion, corporate network density, and a strong specialist-care base underpin demand. Federal scrutiny of local veterinary mergers may influence the structure of future acquisitions, particularly in emergency and specialty markets where geographic alternatives can be limited. Canada represents the remaining 8.88% share and posts a faster 8.1% CAGR, supported by growing urban pet-care expenditure and further room for network development.

Europe

Europe accounts for 27.33% of 2025 global revenue and grows at 7.3% CAGR. The region combines high household pet ownership with established animal-welfare, pharmaceutical, and veterinary-practice regulations. Competition varies sharply by country: the United Kingdom has substantial corporate-chain penetration, whereas Germany, France, Italy, Spain, and the Netherlands retain different ownership restrictions and independent-practice traditions.

Germany had 33.9 million pets in households in 2024, including 15.9 million cats and 10.5 million dogs ^{[7]Zentralverband Zoologischer Fachbetriebe and Industrieverband Heimtierbedarf, The German Pet Market 2024: Structure & Sales Data, 2024, zzf.de}. The United Kingdom had approximately 36 million pets in 2024, including 13.5 million dogs and 12.5 million cats. The U.K. market is also shaped by regulatory attention to practice ownership, pricing, and customer transparency. France's 75.1 million pet population and 61% household ownership rate demonstrate the scale of companion-animal demand in continental Europe. Across the region, tighter controls on antimicrobial use continue to favor preventive herd-health management over routine therapeutic use in production animals.

Asia Pacific

Asia Pacific holds 19.56% of global market value and records the highest regional CAGR at 8.5%. Urbanization, rising disposable income, smaller households, and changing attitudes toward companion animals are increasing veterinary-service demand across China, India, South Korea, Australia, and Japan. The central challenge is not demand creation alone; it is the pace at which clinical infrastructure, insurance, trained professionals, and referral systems can develop alongside it.

China's large and expanding cat population supports demand for urban small-animal hospitals and advanced diagnostics. India offers a different opportunity: companion-animal ownership is increasing from a lower service-intensity base, and Mars Veterinary Health's minority investment in Crown Veterinary Services in 2025 illustrates international interest in scalable Indian hospital networks ^{[8]The Hindu BusinessLine, Mars Veterinary Health enters Indian veterinary segment through investment in Crown Vet, 2025, thehindubusinessline.com}. Australia is the region's most consolidated market. CVS Group's September 2025 acquisition of six Sydney Animal Hospitals expanded its Australian footprint and demonstrated the appeal of established metropolitan hospital clusters. Japan remains a high-spend but demographically mature market, while South Korea's premium urban pet-care segment supports growing demand for specialty and emergency services.

Latin America

Latin America represents 8.49% of global revenue and grows at 6.2% CAGR. Brazil, Mexico, and Argentina are supported by a dual demand base: urban companion-animal care and production-animal veterinary services. Brazil's extensive cattle, poultry, and swine sectors sustain herd-health, reproductive, and disease-control services, while major cities are developing more sophisticated companion-animal emergency and specialty facilities.

Mexico benefits from both urban companion-animal demand and livestock-related veterinary activity. Argentina's production-animal market remains important, but macroeconomic volatility can constrain discretionary household spending on elective companion-animal care. Across the region, clinical infrastructure and affordability vary widely, limiting the pace at which advanced diagnostic and specialty services can diffuse beyond affluent urban areas.

Middle East & Africa

The Middle East & Africa accounts for 4.91% of global revenue and grows at 5.6% CAGR. South Africa provides the most developed sub-Saharan veterinary base, supported by commercial livestock and established urban companion-animal services. Saudi Arabia and the UAE represent the premium end of Middle Eastern demand, with opportunities in companion-animal, equine, import-quarantine, and food-security-related veterinary care.

Growth is constrained by uneven infrastructure, differences in household purchasing power, and varying regulation of private practice and foreign investment. Disease surveillance remains a major public-sector function in livestock-intensive markets, particularly where HPAI and foot-and-mouth disease risks require testing and movement-control systems. Gulf markets can support advanced private services, but their premium urban demand does not offset the wider region's infrastructure gap.

Latin America and the Middle East & Africa have a different demand mix. Companion-animal services are expanding in major cities, but production-animal health, public surveillance, and livestock regulation remain comparatively more important to service utilization. This creates opportunities for targeted hospital formats and mobile or networked veterinary services, while making broad replication of North American specialty-hospital economics less certain. Regulatory conditions, professional supply, and household affordability will determine how quickly those regions can move from basic care toward high-acuity service models.

Veterinary Hospital Market Share & Competitive Landscape

Competition is increasingly shaped by the ability to combine local clinical trust with scale-based capabilities. Independent hospitals compete through continuity of care, community reputation, and convenience. Larger networks differentiate through specialist coverage, diagnostics, emergency capacity, insurance relationships, centralized procurement, digital tools, and access to acquisition capital.

All Pets Veterinary Hospital operates in the independent companion-animal hospital segment, where local relationships, general medicine, dental care, and routine surgery remain core competitive assets.

AniCura is part of Mars Veterinary Health's European network and operates small-animal hospitals with a referral and specialist-care orientation. Its position benefits from access to the broader Mars diagnostics and veterinary-services ecosystem.

Beijing Xintiandi International Animal Hospital participates in China's premium urban companion-animal segment, where demand for advanced diagnostics, specialty consultation, and emergency care is increasing alongside pet ownership and spending.

Belltowne Veterinary Center competes as a community-oriented provider of wellness, vaccination, dental, and surgical services. Its positioning reflects the continued importance of single-site hospitals in local markets.

CVS Group is a major U.K. veterinary services provider with operations across companion-animal, equine, farm-animal, diagnostic, pharmacy, and preventive-care activities. The company reported revenue from continuing operations of £673.2 million for the year ended June 2025, with adjusted EBITDA of £134.6 million ^{[9]CVS Group, Our Strategy, 2025, cvsukltd.co.uk}. Its Australian expansion provides geographic diversification as the U.K. market faces heightened regulatory review.

Fishers Veterinary Hospital operates in the companion-animal general-practice category, where service accessibility, local clinical reputation, and recurring preventive visits are central to retention.

Greencross Vets is a leading Australian pet-care and veterinary operator. Lucas Barry was appointed chief executive officer in November 2024, while TPG Capital explored strategic options for the company following the earlier termination of an EBOS transaction.

Innovative Petcare operates companion-animal hospitals with a preventive-care and standardized-clinical-services focus, positioning its network around recurring wellness utilization.

IVC Evidensia operates approximately 2,600 clinics, hospitals, and out-of-hours centers across 20 countries. Its 2024 acquisition of Vetminds Invest expanded the group into Estonia and Latvia through eight clinics. The network's scale gives it strong purchasing, recruitment, referral, and technology-deployment advantages, although concentrated ownership also attracts increasing regulatory attention.

MaxPetZ serves the Asia Pacific companion-animal care market, where urban clinic expansion and rising owner expectations create demand for accessible veterinary services.

Mars Incorporated is a major global veterinary-services owner through Mars Veterinary Health, which includes Banfield Pet Hospital, VCA Animal Hospitals, BluePearl Specialty and Emergency Pet Hospital, AniCura, and other businesses. Mars completed its acquisition of French veterinary diagnostics businesses Cerba Vet and ANTAGENE in July 2024, extending its diagnostic footprint in France.

Medivet is a U.K.-based veterinary group operating companion-animal practices and competing directly in a market characterized by corporate-network concentration and regulatory scrutiny.

National Veterinary Associates (NVA) operates a large North American network spanning general practice, specialty, emergency, equine hospitals, and pet resorts. NVA appointed Ken Burdick executive chairman in May 2025 as part of preparation for a future initial public offering.

PetVet Care Centers is a U.S. private-equity-backed operator focused on companion-animal general practice and specialty care. Its acquisition-led model reflects continued interest in suburban and metropolitan hospitals with established client bases.

SASH Vets is an Australian specialist and emergency referral-hospital network with capabilities in oncology, cardiology, internal medicine, emergency, and critical care.

The Animal Medical Center is a nonprofit New York City referral hospital with extensive specialty capacity. Its teaching, research, and 24-hour emergency roles distinguish it from corporate network models.

VetPartners is a veterinary group with operations in the U.K., Europe, and Australia. Its veterinarian-partnership approach provides a different ownership and retention model within consolidated markets.

Recent Industry Developments

• January 2024 - IDEXX introduced the inVue Dx Cellular Analyzer: The company launched a slide-free cellular analyzer designed to provide cytology and hematology results within approximately ten minutes.

• January 2024 - Zoetis added AI urine sediment analysis to Vetscan Imagyst: The enhancement expanded the platform's in-clinic diagnostic functionality.

• April 2024 - Antech launched AIS RapidRead: The AI-assisted radiology interpretation service was introduced for companion-animal practices.

• July 2024 - Mars acquired Cerba Vet and ANTAGENE: Mars completed its acquisition of Cerba HealthCare Group's stake in the French veterinary diagnostics businesses.

• September 2024 - Zoetis introduced Vetscan OptiCell: The company announced a cartridge-based AI-powered hematology analyzer for veterinary use.